PD
AZN icon

Point72 (DIFC)’s AstraZeneca AZN Stock Holding History

Point72 (DIFC)’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$792K Sell
5,163
-22,547
-81% -$3.41M 0.05% 212
2025
Q2 		$3.87M Buy
27,710
+3,915
+16% +$549K 0.15% 182
2025
Q1 		$3.5M Sell
23,795
-9,223
-28% -$1.33M 0.14% 199
2024
Q4 		$4.33M Buy
+33,018
New +$4.62M 0.16% 183
2024
Q3 		– Sell
-18,275
Closed -$2.85M – 1454
2024
Q2 		$2.85M Buy
18,275
+12,497
+216% +$1.88M 0.1% 257
2024
Q1 		$783K Buy
+5,778
New +$765K 0.02% 628

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Point72 (DIFC)'s AZN Position: Q3 2025 in Review

Point72 (DIFC) reduced its AstraZeneca (AZN) stake by 81% in Q3 2025, selling an estimated $3.41M and leaving 5,163 shares worth $792K. The position accounts for 0.05% of the portfolio, ranked #212.

Point72 (DIFC) first reported a position in AZN in Q1 2024 and has held it in 6 quarters since. The position peaked at $4.33M in Q4 2024. 1,288 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

  • Point72 (DIFC) held 5,163 shares of AstraZeneca worth $792K as of Q3 2025.
  • Point72 (DIFC) sold 22,547 AstraZeneca shares in Q3 2025, an estimated $3.41M.
  • AstraZeneca made up 0.05% of Point72 (DIFC)'s portfolio in Q3 2025, its #212 holding.
  • Point72 (DIFC) first reported a position in AstraZeneca in Q1 2024 and has held it in 6 quarters since.
  • Point72 (DIFC)'s AstraZeneca position peaked at $4.33M in Q4 2024.
  • 1,288 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.